Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results
Financial Performance: Lakeside Holding Limited reported a 31.3% decrease in total revenues for Q2 2025, primarily due to a decline in cross-border airfreight solutions, resulting in a net loss of $1.9 million compared to a net income of $0.06 million in the same period last year.
Strategic Developments: The company is focusing on long-term growth by expanding its pharmaceutical logistics through Hupan Pharmaceutical and forming partnerships with major e-commerce platforms, which has led to a 29.4% increase in Asia-based customer revenues in the first half of fiscal 2025.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on LSH
About LSH
About the author
Lakeside Holding files to sell 7.4M shares of common stock for holders
Lakeside Holding Stock Offering: Lakeside Holding (LSH) has filed to sell 7.4 million shares of common stock for its holders.
Recent Company Developments: The company has announced board resignations and appointments, as well as secured new distribution agreements with Kelun Pharmaceutical.
LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION
Securities Purchase Agreement: Lakeside Holding Limited has entered into a securities purchase agreement to sell up to $4.5 million in senior secured convertible promissory notes, with the first tranche generating approximately $930,000 in gross proceeds.
Company Overview: Lakeside is a U.S.-based supply chain solution provider focused on the Asia-Pacific market, operating through its subsidiaries American Bear Logistics and Hupan Pharmaceutical, enhancing its logistics capabilities in both general and pharmaceutical sectors.
